Back to results
US 9,439,960 B2Granted
Cytomegalovirus vaccines and methods of production
AssigneeThe Trustees of Princeton University
InventorsThomas Shenk, Dai Wang
Life of this patent
Estimating the term…
Abstract
Methods of increasing diversity in cytomegalovirus vaccines through the selection of cell type in which the virus is propagated, and the use of cytomegalovirus produced by those methods in the development of vaccine compositions, are disclosed. Vaccine compositions comprising CMV isolated from epithelial cells are also disclosed.
Claims3
A method of making an immunogenic composition comprising a population of live attenuated, inactivated or killed cytomegaloviruses (CMVs), or virion components thereof, comprising:
- a) passaging two or more strains or isolates of CMV having a gene encoding a functional pUL131 protein in a fibroblast,
- b) amplifying the two or more strains or isolates of CMV in an epithelial cell, thereby producing cell type-conditioned CMVs;
- and
- c) producing a population of live attenuated, inactivated, or killed CMVs from the cell type-conditioned CMVs, thereby producing the immunogenic composition.
1 more element
Dependencies are inferred from the claim text.